Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Blood. 2010 Dec 9;116(24):5368-70. doi: 10.1182/blood-2010-06-289488. Epub 2010 Sep 10.
Hemoglobin E β thalassemia is the commonest form of severe thalassemia in many Asian countries. Its remarkably variable clinical phenotype presents a major challenge to determining its most appropriate management. In particular, it is not clear why some patients with this condition can develop and function well at very low hemoglobin levels. Here, we demonstrate that patients with hemoglobin Eβ thalassemia have a significant decrease in the oxygen affinity of their hemoglobin, that is an increased P(50) value, in response to anemia. This may in part reflect the lower level of hemoglobin F in this condition compared with other forms of β thalassemia intermedia. The ability to right-shift the oxygen dissociation curve was retained across the spectrum of mild and severe phenotypes, despite the significantly higher levels of hemoglobin F in the former, suggesting that efforts directed at producing a modest increase in the level of hemoglobin F in symptomatic patients with this disease should be of therapeutic value.
血红蛋白 E β 地中海贫血症是许多亚洲国家最常见的严重地中海贫血症形式。其显著变化的临床表现对确定其最合适的治疗方案提出了重大挑战。特别是,为什么有些患有这种疾病的患者可以在极低的血红蛋白水平下很好地发育和发挥功能还不清楚。在这里,我们证明了血红蛋白 Eβ 地中海贫血症患者的血红蛋白对氧的亲和力显著降低,即 P(50)值增加,以应对贫血。这可能部分反映了与其他中间型β地中海贫血症相比,这种情况下的血红蛋白 F 水平较低。尽管前者的血红蛋白 F 水平显著升高,但在轻度和重度表型范围内,氧离解曲线的右移能力仍然保留,这表明在有症状的此类疾病患者中,努力适度增加血红蛋白 F 水平应该具有治疗价值。